4.
36例乳腺癌术后蒽环类药物化疗结束血hs-cTnI≤0.1 ng/mL与 > 0.1 ng/mL患者3D-STI参数及血生化参数比较
Comparison of 3D- STI parameters and biochemical parameters after anthracycline chemotherapy between with blood hs-cTnI ≤0.1 ng/mL and > 0.1 ng /mL
| Group | RVGLS (%) | RVGCS (%) | RVGRS (%) | RVGAS (%) | hs-cTnI (ng/mL) | NT-proBNP (pg/mL) |
| A: At the end of chemotherapy, hs-cTnI ≤0.1 ng/mL; B: At the end of chemotherapy, hs-cTnI > 0.1 ng/mL. | ||||||
| A (n=21) | -16.71±1.86 | -18.11±1.68 | 72.14±5.58 | -23.75±3.02 | 0.094±0.016 | 43.41±3.91 |
| B (n=15) | -13.03±2.17 | -17.23±1.39 | 71.73±4.96 | -18.08±3.16 | 0.122±0.012 | 45.04±5.24 |
| t | 5.44 | 1.66 | -0.23 | 5.55 | 1.54 | 0.08 |
| P | 0 | 0.11 | 0.82 | 0 | 0.13 | 0.98 |